Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA.
Identifieur interne : 000B01 ( Ncbi/Checkpoint ); précédent : 000B00; suivant : 000B02Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA.
Auteurs : Steffen Nock [États-Unis]Source :
- IDrugs : the investigational drugs journal [ 1369-7056 ] ; 2004.
Descripteurs français
- KwdFr :
- Animaux, Anticorps monoclonaux, Conception de médicament, Humains, Industrie pharmaceutique, Internationalité, Médicaments en essais cliniques, Philadelphie, Recherche (tendances), Technologie pharmaceutique, VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie), Virus du SRAS (immunologie).
- MESH :
English descriptors
- KwdEn :
- MESH :
- chemical : Antibodies, Monoclonal, Drugs, Investigational.
- immunology : HIV-1, SARS Virus.
- trends : Research.
- Animals, Drug Design, Drug Industry, Humans, Internationality, Philadelphia, Technology, Pharmaceutical.
Abstract
Overall, the sessions were well attended and a lot of questions were asked. Two-thirds of the speakers were from industry and the rest from academia. Of particular note, The academics presented cutting-edge science in the antibody discovery and development area. Business representatives from various therapeutic antibody companies discussed in detail various aspects and challenges of building a viable therapeutic antibody company.
PubMed: 15470596
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002B27
- to stream PubMed, to step Curation: 002B27
- to stream PubMed, to step Checkpoint: 002E28
- to stream Ncbi, to step Merge: 000B01
- to stream Ncbi, to step Curation: 000B01
Links to Exploration step
pubmed:15470596Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA.</title><author><name sortKey="Nock, Steffen" sort="Nock, Steffen" uniqKey="Nock S" first="Steffen" last="Nock">Steffen Nock</name><affiliation wicri:level="2"><nlm:affiliation>Absalus Inc, 2464 Wyandotte Street, Mountain View, CA 94043, USA. snock@abslus.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Absalus Inc, 2464 Wyandotte Street, Mountain View, CA 94043</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15470596</idno><idno type="pmid">15470596</idno><idno type="wicri:Area/PubMed/Corpus">002B27</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B27</idno><idno type="wicri:Area/PubMed/Curation">002B27</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B27</idno><idno type="wicri:Area/PubMed/Checkpoint">002E28</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002E28</idno><idno type="wicri:Area/Ncbi/Merge">000B01</idno><idno type="wicri:Area/Ncbi/Curation">000B01</idno><idno type="wicri:Area/Ncbi/Checkpoint">000B01</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA.</title><author><name sortKey="Nock, Steffen" sort="Nock, Steffen" uniqKey="Nock S" first="Steffen" last="Nock">Steffen Nock</name><affiliation wicri:level="2"><nlm:affiliation>Absalus Inc, 2464 Wyandotte Street, Mountain View, CA 94043, USA. snock@abslus.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Absalus Inc, 2464 Wyandotte Street, Mountain View, CA 94043</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author></analytic><series><title level="j">IDrugs : the investigational drugs journal</title><idno type="ISSN">1369-7056</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antibodies, Monoclonal</term><term>Drug Design</term><term>Drug Industry</term><term>Drugs, Investigational</term><term>HIV-1 (immunology)</term><term>Humans</term><term>Internationality</term><term>Philadelphia</term><term>Research (trends)</term><term>SARS Virus (immunology)</term><term>Technology, Pharmaceutical</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Anticorps monoclonaux</term><term>Conception de médicament</term><term>Humains</term><term>Industrie pharmaceutique</term><term>Internationalité</term><term>Médicaments en essais cliniques</term><term>Philadelphie</term><term>Recherche (tendances)</term><term>Technologie pharmaceutique</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie)</term><term>Virus du SRAS (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antibodies, Monoclonal</term><term>Drugs, Investigational</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV-1</term><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Recherche</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Research</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Drug Design</term><term>Drug Industry</term><term>Humans</term><term>Internationality</term><term>Philadelphia</term><term>Technology, Pharmaceutical</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Anticorps monoclonaux</term><term>Conception de médicament</term><term>Humains</term><term>Industrie pharmaceutique</term><term>Internationalité</term><term>Médicaments en essais cliniques</term><term>Philadelphie</term><term>Technologie pharmaceutique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Overall, the sessions were well attended and a lot of questions were asked. Two-thirds of the speakers were from industry and the rest from academia. Of particular note, The academics presented cutting-edge science in the antibody discovery and development area. Business representatives from various therapeutic antibody companies discussed in detail various aspects and challenges of building a viable therapeutic antibody company.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li></region></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Nock, Steffen" sort="Nock, Steffen" uniqKey="Nock S" first="Steffen" last="Nock">Steffen Nock</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B01 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000B01 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:15470596
|texte= Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:15470596" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |